PAVmed Inc. (PAVMZ) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
360 MADISON AVENUE NEW YORK, NY 10017 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 1,185 | 765 | 25,499 | 25,536 | 19,639 | 26,408 | |||
| Cash and cash equivalent | 1,185 | 765 | 25,499 | 25,536 | 19,639 | 26,408 | |||
| Receivables | 18 | 16 | 219 | 67 | 61 | 36 | |||
| Inventory, net of allowances, customer advances and progress billings | 6 | 687 | 410 | 278 | |||||
| Inventory | 6 | 687 | 410 | 278 | |||||
| Prepaid expense | 233 | 420 | 872 | 520 | 848 | 479 | |||
| Other undisclosed current assets | 728 | 923 | 2,930 | 3,041 | 3,672 | 5,538 | |||
| Total current assets: | 2,164 | 2,130 | 30,207 | 29,574 | 24,498 | 32,461 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 2,500 | 2,618 | 5,771 | 3,886 | 4,267 | 4,663 | |||
| Property, plant and equipment | 151 | 216 | 1,331 | 1,595 | 1,783 | 1,820 | |||
| Long-term investments and receivables | 25,637 | 25,511 | |||||||
| Long-term investments | 25,637 | 25,511 | |||||||
| Intangible assets, net (including goodwill) | 947 | 1,052 | 1,424 | 1,929 | |||||
| Intangible assets, net (excluding goodwill) | 947 | 1,052 | 1,424 | 1,929 | |||||
| Other noncurrent assets | 208 | 75 | 1,157 | 1,147 | 1,147 | 1,147 | |||
| Total noncurrent assets: | 28,496 | 28,420 | 9,206 | 7,680 | 8,621 | 9,559 | |||
| TOTAL ASSETS: | 30,660 | 30,550 | 39,413 | 37,254 | 33,119 | 42,020 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 5,176 | 5,008 | 8,021 | 8,142 | 6,626 | 7,650 | |||
| Accounts payable | 657 | 465 | 1,232 | 1,485 | 1,786 | 2,165 | |||
| Accrued liabilities | 5,176 | 4,543 | 6,789 | 6,657 | 6,626 | 5,485 | |||
| Other undisclosed accounts payable and accrued liabilities | (657) | (1,786) | |||||||
| Debt | 29,100 | 32,050 | 44,000 | 45,540 | 44,200 | 44,990 | |||
| Derivative instruments and hedges, liabilities | 291 | ||||||||
| Other undisclosed current liabilities | 1,170 | 499 | 1,369 | 1,333 | 3,351 | 1,574 | |||
| Total current liabilities: | 35,446 | 37,557 | 53,390 | 55,015 | 54,177 | 54,505 | |||
| Noncurrent Liabilities | |||||||||
| Liabilities, other than long-term debt | 2,247 | 2,380 | 4,665 | 2,814 | 2,960 | 3,343 | |||
| Operating lease, liability | 2,247 | 2,380 | 4,665 | 2,814 | 2,960 | 3,343 | |||
| Total noncurrent liabilities: | 2,247 | 2,380 | 4,665 | 2,814 | 2,960 | 3,343 | |||
| Total liabilities: | 37,693 | 39,937 | 58,055 | 57,829 | 57,137 | 57,848 | |||
| Temporary equity, including noncontrolling interest | |||||||||
| Equity | |||||||||
| Equity, attributable to parent, including: | (2,495) | (4,869) | (73,945) | (68,780) | (53,831) | (43,259) | |||
| Preferred stock | 3,316 | 3,232 | 3,151 | 3,071 | 2,993 | 2,916 | |||
| Common stock | 11 | 11 | 10 | 9 | 9 | 120 | |||
| Additional paid in capital | 249,143 | 248,200 | 243,524 | 237,863 | 237,600 | 232,234 | |||
| Accumulated deficit | (254,965) | (256,312) | (320,630) | (309,723) | (294,433) | (278,529) | |||
| Other undisclosed equity, attributable to parent | |||||||||
| Equity, attributable to noncontrolling interest | (4,538) | (4,518) | 55,303 | 48,205 | 29,813 | 27,431 | |||
| Total equity: | (7,033) | (9,387) | (18,642) | (20,575) | (24,018) | (15,828) | |||
| TOTAL LIABILITIES AND EQUITY: | 30,660 | 30,550 | 39,413 | 37,254 | 33,119 | 42,020 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 1,000 | 1,000 | 1,000 | 1,097 | 791 | |||
| Net investment income | 2 | 70 | 110 | 72 | 97 | 124 | ||
| Cost of revenue | (48) | (1,381) | (1,666) | (1,744) | (1,611) | (1,779) | ||
| Gross profit: | (48) | (381) | (666) | (744) | (514) | (988) | ||
| Operating expenses | (5,149) | (11,193) | (12,997) | (13,302) | (15,821) | (14,540) | ||
| Other undisclosed operating income (loss) | 10 | (4) | (21) | 10 | (48) | |||
| Operating loss: | (5,187) | (11,578) | (13,684) | (14,036) | (16,383) | (15,528) | ||
| Nonoperating income (expense) | 6,329 | 72,289 | (1,230) | (4,476) | (1,025) | (6,222) | ||
| Investment income, nonoperating | 72,287 | |||||||
| Other nonoperating expense | (1,025) | (6,222) | ||||||
| Interest and debt expense | (1,403) | (763) | (369) | (750) | (1,764) | |||
| Income (loss) from continuing operations before equity method investments, income taxes: | 1,142 | 59,308 | (15,677) | (18,881) | (18,158) | (23,514) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 1,403 | 763 | 369 | 750 | 1,764 | |||
| Net income (loss): | 1,142 | 60,711 | (14,914) | (18,512) | (17,408) | (21,750) | ||
| Net income attributable to noncontrolling interest | 289 | 3,688 | 4,087 | 3,300 | 3,372 | 4,079 | ||
| Net income (loss) attributable to parent: | 1,431 | 64,399 | (10,827) | (15,212) | (14,036) | (17,671) | ||
| Preferred stock dividends and other adjustments | (85) | (83) | (81) | (80) | (78) | (77) | ||
| Other undisclosed net loss available to common stockholders, basic | (7,496) | (1,791) | ||||||
| Net income (loss) available to common stockholders, diluted: | 1,346 | 64,316 | (10,908) | (22,788) | (15,905) | (17,748) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 1,142 | 60,711 | (14,914) | (18,512) | (17,408) | (21,750) | ||
| Comprehensive income (loss): | 1,142 | 60,711 | (14,914) | (18,512) | (17,408) | (21,750) | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | 289 | 3,688 | 4,087 | 3,300 | 3,372 | 4,079 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 1,431 | 64,399 | (10,827) | (15,212) | (14,036) | (17,671) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.